🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of Oral Az...
Status
Active Not Recruiting
Location
Local Institution - 0031
Start Date
2022-08-19
Trial ID
NCT05413018
This study evaluates the efficacy of Oral azacitidine versus single-agent I...
Status
Completed
Location
University Hospital for Internal Medicine - University Hospital Graz
Start Date
2018-11-09
Trial ID
NCT03593018
Treatments Being Tested
You are being asked to take part in this study because you have advanced me...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-02-14
Trial ID
NCT02816021
Treatments Being Tested
This phase I/II trial studies the best dose, possible benefits and/or side ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2022-06-29
Trial ID
NCT05141682
Treatments Being Tested
Background: T-cell lymphomas (TCLs) are rare cancers. Many types of TCLs d...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2022-11-03
Trial ID
NCT04639843
Treatments Being Tested
Rollover study supporting hematological disorder indications from Celgene s...
Status
Completed
Location
Local Institution - 101
Start Date
2015-10-22
Trial ID
NCT02494258
Treatments Being Tested
Background: Mature T-cell malignancies (TCMs) are a rare group of cancers ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-12-17
Trial ID
NCT04447027
This phase I/Ib trial investigates the side effects of CC-486 and how well ...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2020-10-23
Trial ID
NCT04578600
Treatments Being Tested
Approximately 30% of adult AML subjects are refractory to induction therapy...
Status
Recruiting
Location
Amiens CHU
Start Date
2024-01-13
Trial ID
NCT06022003
Treatments Being Tested
This study enrolled 472 participants, aged 55 or older, with a diagnosis of...
Status
Completed
Location
Arizona Oncology Associates, P.C.
Start Date
2013-04-24
Trial ID
NCT01757535
Treatments Being Tested